1. Home
  2. BIO vs ALLE Comparison

BIO vs ALLE Comparison

Compare BIO & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • ALLE
  • Stock Information
  • Founded
  • BIO 1952
  • ALLE 2013
  • Country
  • BIO United States
  • ALLE Ireland
  • Employees
  • BIO N/A
  • ALLE N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • ALLE Diversified Commercial Services
  • Sector
  • BIO Industrials
  • ALLE Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • ALLE Nasdaq
  • Market Cap
  • BIO 9.2B
  • ALLE 10.9B
  • IPO Year
  • BIO N/A
  • ALLE N/A
  • Fundamental
  • Price
  • BIO $279.94
  • ALLE $127.17
  • Analyst Decision
  • BIO Strong Buy
  • ALLE Hold
  • Analyst Count
  • BIO 4
  • ALLE 6
  • Target Price
  • BIO $414.00
  • ALLE $138.33
  • AVG Volume (30 Days)
  • BIO 264.6K
  • ALLE 985.2K
  • Earning Date
  • BIO 02-13-2025
  • ALLE 02-18-2025
  • Dividend Yield
  • BIO N/A
  • ALLE 1.61%
  • EPS Growth
  • BIO N/A
  • ALLE 11.44
  • EPS
  • BIO N/A
  • ALLE 6.82
  • Revenue
  • BIO $2,566,500,000.00
  • ALLE $3,772,200,000.00
  • Revenue This Year
  • BIO $4.19
  • ALLE $5.24
  • Revenue Next Year
  • BIO $4.75
  • ALLE $3.67
  • P/E Ratio
  • BIO N/A
  • ALLE $18.55
  • Revenue Growth
  • BIO N/A
  • ALLE 3.33
  • 52 Week Low
  • BIO $262.12
  • ALLE $113.27
  • 52 Week High
  • BIO $387.99
  • ALLE $156.10
  • Technical
  • Relative Strength Index (RSI)
  • BIO 26.04
  • ALLE 41.23
  • Support Level
  • BIO $273.67
  • ALLE $124.19
  • Resistance Level
  • BIO $289.96
  • ALLE $134.25
  • Average True Range (ATR)
  • BIO 11.05
  • ALLE 2.43
  • MACD
  • BIO -6.71
  • ALLE -0.33
  • Stochastic Oscillator
  • BIO 7.40
  • ALLE 29.60

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About ALLE Allegion plc

Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2023, Allegion generated 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy and Switzerland-based Dormakaba.

Share on Social Networks: